Chemotherapy delays pancreatic cancer recurrence
The use of the drug gemcitabine for chemotherapy significantly delays the recurrence of pancreatic cancer compared to no chemotherapy, a study has shown.
Sign in
In order to continue you need to be a registered user. If you would like to register to Nursing Times then click here.
